Utilization of Immediate Postpartum Contraception and Its Association with Interpregnancy Interval: 10-Year Experience at a Single Center

Abstract

Objective Increasing availability of immediate postpartum long-acting reversible contraception (LARC) has added contraceptive alternatives to bilateral tubal ligation (BTL) in the immediate postpartum period. The resultant access to long-term contraception has provided patients with improved control over the timing of pregnancies. Our objective is to evaluate changes in the utilization of immediate postpartum contraceptive methods over a 10-year period and its association with interpregnancy interval (IPI).

Study Design Retrospective cohort study of 36,445 patients delivered at a single academic hospital center from 2012 to 2020. Deliveries <23 weeks gestation and patients who underwent a cesarean hysterectomy or postpartum hysterectomy for obstetric indications were excluded. The primary outcome was the utilization of postpartum BTL, intrauterine devices, contraceptive implants, and Depo-Provera over the study time period. The secondary outcomes were IPI and interdelivery interval (IDI). Outcomes were compared using appropriate tests of trend. We adjusted for significant covariates as assessed in baseline characteristics.

Results A total of 35,281 patients were included in our study. Groups were different in baseline characteristics including age, race/ethnicity, parity, BMI, insurance status, comorbidity risk, and attendance at postpartum exam. Over the study period, there was a significant difference in utilization of Depo-Provera, LARC, intrauterine device (IUD), and implant (p < 0.001). There was a significant increase in IPI (p < 0.001) and IDI (p < 0.001).

Conclusion We observed a significant increase in utilization of immediate postpartum LARC over the study period which corresponded to a significant increase in IPI and IDI. Our findings emphasize the importance of the availability of immediate postpartum contraception as well as its effectiveness in improving family planning options for reproductive-aged patients. We found significantly increased IPI and IDI associated with increased utilization of long-acting reversible contraceptives immediately postpartum. Our findings emphasize the importance of providers offering these options to patients as well as being comfortable initiating immediate postpartum contraception.

Key Points

• Immediate postpartum LARC access has increased over the past 10 years.

• Access to more methods of contraception allows patients more options for family planning.

• Increased utilization of LARC led to increased IPI and IDI.

Keywords

contraception - interpregnancy interval - postpartum contraception - LARC

Note

All individuals who contributed to this work have met the standard criteria for authorship.

Publication History

Received: 24 April 2024

Accepted: 06 August 2024

Article published online:
03 September 2024

• References

• 1 Swan LET. The impact of US policy on contraceptive access: a policy analysis. Reprod Health 2021; 18 (01) 235
• 2 Frost JJZM, Frohwirth L. Contraceptive Needs and Services, 2010. New York: Guttmacher Institute; 2013. . Accessed August 12, 2024 at: http://www.guttmacher.org/pubs/win/contraceptive-needs-2010.pdf
• 3 American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Committee Opinion No. 670: Immediate postpartum long-acting reversible contraception. Obstet Gynecol 2016; 128 (02) e32-e37
• 4 American College of Obstetricians and Gynecologists. Medicaid Reimbursement for Postpartum LARC. 2022 ACOG Resources. “Medicaid Reimbursement for Postpartum LARC. Accessed August 12, 2024 at: https://www.acog.org/programs/long-acting-reversible-contraception-larc/activities-initiatives/ edicaid-reimbursement-for-postpartum-larc
• 5 Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Rep 2015; (86) 1-14 . Accessed August 12, 2024 at: https://www.ncbi.nlm.nih.gov/pubmed/26556545
• 6 Kavanaugh ML, Jerman J, Finer LB. Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009–2012. Obstet Gynecol 2015; 126 (05) 917-927
• 7 Whiteman MK, Cox S, Tepper NK. et al. Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States. Am J Obstet Gynecol 2012; 206 (02) 127.e1-127.e7
• 8 Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61 (04) 344-349
• 9 University of California, San Francisco. UCSF Bixby Center LARC Project. Accessed August 12, 2024 at: https://intranet.bixbycenter.ucsf.edu/research/cd_and_fp/larc.html
• 10 White K, Teal SB, Potter JE. Contraception after delivery and short interpregnancy intervals among women in the United States. Obstet Gynecol 2015; 125 (06) 1471-1477
• 11 Smith M, McCool-Myers M, Kottke MJ. Analysis of postpartum uptake of long-acting reversible contraceptives before and after implementation of Medicaid reimbursement policy. Matern Child Health J 2021; 25 (09) 1361-1368
• 12 Liberty A, Yee K, Darney BG, Lopez-Defede A, Rodriguez MI. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations. Am J Obstet Gynecol 2020; 222 (4S): 886.e1-886.e9